Thrive Person-Centered Planning Program for Young Adults With Fetal Alcohol Spectrum Disorders
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study is testing a new program called Thrive. The Thrive program was developed for young adults with fetal alcohol spectrum disorders (FASD). Thrive uses a person-centered planning approach, which means it focuses on what is most important to the young adult with FASD. The young adult invites people that support them to help them make plans to meet their goals. 60 young adults with FASD will participate in this study. Half of the young adults will try out the Thrive program immediately. The other half will be on a waitlist and will get to start the program about 8 months later. Everyone completes online surveys at three times during the study. They do surveys at the beginning of the study, after 4 months, and after 8 months. The goal of the study is to test if the Thrive program helps young adults meet their goals and get support when they need it.
Full description
This type 1 hybrid effectiveness-implementation trial proposes a 2-arm parallel pilot RCT design. A total of 60 young adults with FASD will be randomly assigned into the (1) Thrive intervention or the (2) waitlist comparison group using a 50:50 allocation ratio. As this is a type 1 hybrid trial, measurement emphasizes effectiveness outcomes, with collection of some implementation outcomes/process to inform planning of subsequent larger scale community trials. Consistent with the pilot RCT design, analysis will focus on determining feasibility of the intervention, trial procedures and measurement, and intervention process. This information will optimize success of the planned R01 larger-scale RCT.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Young adult between the ages of 18 and 25
- Lives in the United States
- Has a diagnosis of fetal alcohol spectrum disorder or confirmed prenatal alcohol exposure
Exclusion criteria
- Does not have access to the internet or data plan allowing video conferencing
- Is not able to listen or speak in English
Trial design
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Christie Petrenko, Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal